Allied World Assurance Stock To Go Ex-dividend Tomorrow (AWH)

NEW YORK ( TheStreet) -- The ex-dividend date for Allied World Assurance Company Holdings (NYSE: AWH) is tomorrow, March 28, 2012. Owners of shares as of market close today will be eligible for a dividend of 38 cents per share. At a price of $70.27 as of 9:30 a.m. ET, the dividend yield is 2.2%.

The average volume for Allied World Assurance has been 288,200 shares per day over the past 30 days. Allied World Assurance has a market cap of $2.37 billion and is part of the financial sector and insurance industry. Shares are up 9.8% year to date as of the close of trading on Monday.

Allied World Assurance Company Holdings, AG operates as a specialty insurance and reinsurance company in Bermuda, Hong Kong, Ireland, Singapore, Switzerland, the United Kingdom, and the United States. The company has a P/E ratio of 10, below the average insurance industry P/E ratio of 13.6 and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Allied World Assurance as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, solid stock price performance and increase in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. You can view the full Allied World Assurance Ratings Report.

See our dividend calendar or top-yielding stocks list.

null

More from Markets

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

Zoom CEO Eric Yuan Leads Glassdoor's List of Top 100 CEOs

Zoom CEO Eric Yuan Leads Glassdoor's List of Top 100 CEOs

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Purdue Pharma Unloads Sales Staff, Transitioning From Painkiller Focus

Purdue Pharma Unloads Sales Staff, Transitioning From Painkiller Focus